Nicotine Potentiation of Excitatory Inputs to Ventral Tegmental Area Dopamine Neurons
Drug-induced changes in synaptic strength are hypothesized to contribute to appetitive behavior and addiction. Nicotine, the major addictive substance in tobacco, activates nicotinic receptors (nAChRs) to initiate a series of adaptive changes at the cellular and circuit levels in brain, particularly...
Saved in:
Published in | The Journal of neuroscience Vol. 31; no. 18; pp. 6710 - 6720 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Society for Neuroscience
04.05.2011
|
Subjects | |
Online Access | Get full text |
ISSN | 0270-6474 1529-2401 1529-2401 |
DOI | 10.1523/JNEUROSCI.5671-10.2011 |
Cover
Abstract | Drug-induced changes in synaptic strength are hypothesized to contribute to appetitive behavior and addiction. Nicotine, the major addictive substance in tobacco, activates nicotinic receptors (nAChRs) to initiate a series of adaptive changes at the cellular and circuit levels in brain, particularly the ventral tegmental area (VTA). Our laboratory previously reported that nicotine facilitates induction of long-term potentiation (LTP) in VTA dopamine (DA) neurons by increasing glutamate release via activation of α7 nAChRs on the glutamate terminals, suggesting a critical presynaptic contribution of nicotine in LTP induction. In the present study, we used an in vitro exposure paradigm to study the effect of nicotine on excitatory synaptic strength. Brief exposure of nicotine to brain slices from drug-naive adult rats followed by a period of recovery resulted in an NMDA receptor (NMDAR)-dependent increase of AMPA receptor/NMDAR ratio in VTA DA neurons, which is consistent with the induction of LTP. These effects are similar to that induced by a single in vivo nicotine injection intraperitoneally. The induction of synaptic potentiation required excitation of DA neurons mediated by somatodendritic α4β2 nAChRs, as well as enhancement of NMDAR function via D 5 dopamine receptors, also on DA neurons. Nicotine-induced increase of presynaptic glutamate release also contributed to the induction of synaptic plasticity, likely through increased activation of NMDAR. These results identified important receptor systems involved in nicotine-induced long-term changes in excitatory synaptic input to VTA DA neurons. The data also revealed remarkable similarity in the mechanisms underlying synaptic plasticity induced by nicotine and cocaine in the VTA. |
---|---|
AbstractList | Drug-induced changes in synaptic strength are hypothesized to contribute to appetitive behavior and addiction. Nicotine, the major addictive substance in tobacco, activates nicotinic receptors (nAChRs) to initiate a series of adaptive changes at the cellular and circuit levels in brain, particularly the ventral tegmental area (VTA). Our laboratory previously reported that nicotine facilitates induction of long-term potentiation (LTP) in VTA dopamine (DA) neurons by increasing glutamate release via activation of α7 nAChRs on the glutamate terminals, suggesting a critical presynaptic contribution of nicotine in LTP induction. In the present study, we used an in vitro exposure paradigm to study the effect of nicotine on excitatory synaptic strength. Brief exposure of nicotine to brain slices from drug-naive adult rats followed by a period of recovery resulted in an NMDA receptor (NMDAR)-dependent increase of AMPA receptor/NMDAR ratio in VTA DA neurons, which is consistent with the induction of LTP. These effects are similar to that induced by a single in vivo nicotine injection intraperitoneally. The induction of synaptic potentiation required excitation of DA neurons mediated by somatodendritic α4β2 nAChRs, as well as enhancement of NMDAR function via D 5 dopamine receptors, also on DA neurons. Nicotine-induced increase of presynaptic glutamate release also contributed to the induction of synaptic plasticity, likely through increased activation of NMDAR. These results identified important receptor systems involved in nicotine-induced long-term changes in excitatory synaptic input to VTA DA neurons. The data also revealed remarkable similarity in the mechanisms underlying synaptic plasticity induced by nicotine and cocaine in the VTA. Drug-induced changes in synaptic strength are hypothesized to contribute to appetitive behavior and addiction. Nicotine, the major addictive substance in tobacco, activates nicotinic receptors (nAChRs) to initiate a series of adaptive changes at the cellular and circuit levels in brain, particularly the ventral tegmental area (VTA). Our laboratory previously reported that nicotine facilitates induction of long-term potentiation (LTP) in VTA dopamine (DA) neurons by increasing glutamate release via activation of α7 nAChRs on the glutamate terminals, suggesting a critical presynaptic contribution of nicotine in LTP induction. In the present study, we used an in vitro exposure paradigm to study the effect of nicotine on excitatory synaptic strength. Brief exposure of nicotine to brain slices from drug-naive adult rats followed by a period of recovery resulted in an NMDA receptor (NMDAR)-dependent increase of AMPA receptor/NMDAR ratio in VTA DA neurons, which is consistent with the induction of LTP. These effects are similar to that induced by a single in vivo nicotine injection intraperitoneally. The induction of synaptic potentiation required excitation of DA neurons mediated by somatodendritic α4β2 nAChRs, as well as enhancement of NMDAR function via D 5 dopamine receptors, also on DA neurons. Nicotine-induced increase of presynaptic glutamate release also contributed to the induction of synaptic plasticity, likely through increased activation of NMDAR. These results identified important receptor systems involved in nicotine-induced long-term changes in excitatory synaptic input to VTA DA neurons. The data also revealed remarkable similarity in the mechanisms underlying synaptic plasticity induced by nicotine and cocaine in the VTA. Drug-induced changes in synaptic strength are hypothesized to contribute to appetitive behavior and addiction. Nicotine, the major addictive substance in tobacco, activates nicotinic receptors (nAChRs) to initiate a series of adaptive changes at the cellular and circuit levels in brain, particularly the ventral tegmental area (VTA). Our laboratory previously reported that nicotine facilitates induction of long-term potentiation (LTP) in VTA dopamine (DA) neurons by increasing glutamate release via activation of α7 nAChRs on the glutamate terminals, suggesting a critical presynaptic contribution of nicotine in LTP induction. In the present study, we used an in vitro exposure paradigm to study the effect of nicotine on excitatory synaptic strength. Brief exposure of nicotine to brain slices from drug-naive adult rats followed by a period of recovery resulted in an NMDA receptor (NMDAR)-dependent increase of AMPA receptor/NMDAR ratio in VTA DA neurons, which is consistent with the induction of LTP. These effects are similar to that induced by a single in vivo nicotine injection intraperitoneally. The induction of synaptic potentiation required excitation of DA neurons mediated by somatodendritic α4β2 nAChRs, as well as enhancement of NMDAR function via D(5) dopamine receptors, also on DA neurons. Nicotine-induced increase of presynaptic glutamate release also contributed to the induction of synaptic plasticity, likely through increased activation of NMDAR. These results identified important receptor systems involved in nicotine-induced long-term changes in excitatory synaptic input to VTA DA neurons. The data also revealed remarkable similarity in the mechanisms underlying synaptic plasticity induced by nicotine and cocaine in the VTA.Drug-induced changes in synaptic strength are hypothesized to contribute to appetitive behavior and addiction. Nicotine, the major addictive substance in tobacco, activates nicotinic receptors (nAChRs) to initiate a series of adaptive changes at the cellular and circuit levels in brain, particularly the ventral tegmental area (VTA). Our laboratory previously reported that nicotine facilitates induction of long-term potentiation (LTP) in VTA dopamine (DA) neurons by increasing glutamate release via activation of α7 nAChRs on the glutamate terminals, suggesting a critical presynaptic contribution of nicotine in LTP induction. In the present study, we used an in vitro exposure paradigm to study the effect of nicotine on excitatory synaptic strength. Brief exposure of nicotine to brain slices from drug-naive adult rats followed by a period of recovery resulted in an NMDA receptor (NMDAR)-dependent increase of AMPA receptor/NMDAR ratio in VTA DA neurons, which is consistent with the induction of LTP. These effects are similar to that induced by a single in vivo nicotine injection intraperitoneally. The induction of synaptic potentiation required excitation of DA neurons mediated by somatodendritic α4β2 nAChRs, as well as enhancement of NMDAR function via D(5) dopamine receptors, also on DA neurons. Nicotine-induced increase of presynaptic glutamate release also contributed to the induction of synaptic plasticity, likely through increased activation of NMDAR. These results identified important receptor systems involved in nicotine-induced long-term changes in excitatory synaptic input to VTA DA neurons. The data also revealed remarkable similarity in the mechanisms underlying synaptic plasticity induced by nicotine and cocaine in the VTA. |
Author | McGehee, Daniel S. Mao, Danyan Gallagher, Keith |
Author_xml | – sequence: 1 givenname: Danyan surname: Mao fullname: Mao, Danyan – sequence: 2 givenname: Keith surname: Gallagher fullname: Gallagher, Keith – sequence: 3 givenname: Daniel S. surname: McGehee fullname: McGehee, Daniel S. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21543600$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUcFO3DAQtRAVLNv-Asqtp2xtx4kTqaqEli0sWi1Vy_ZqOc4EXCX2YjsV_H0dFlaUC6d5mvfmzWjeCTo01gBCpwTPSE6zL1frxebn9a_5cpYXnKSxTTEhB2gS2SqlDJNDNMGU47RgnB2jE-__YIw5JvwIHVOSs6zAeII2a61s0AaSHzaACVoGbU1i22TxoHSQwbrHZGm2Q_BJsMnvKHGyS27gto8wojMHMjm3W9mPJmsYnDX-I_rQys7Dp-c6RZvvi5v5Zbq6vljOz1apYiQLKaU5qXgFqiqhylkEeV0rVtQ1qTlw1SgJuICMKVW1DLKsKSPR5KppaFmQNpuibzvf7VD30KjddWLrdC_do7BSi_8Zo-_Erf0rMkJKVpXR4POzgbP3A_ggeu0VdJ00YAcvyiInJS9pFZWnr1ftd7y8MgqKnUA5672Ddi8hWIyZiX1mYsxsbI-ZxcGvbwafHh9jiCfr7r3xf5x-oJU |
CitedBy_id | crossref_primary_10_1002_cne_24471 crossref_primary_10_1126_science_aaw8806 crossref_primary_10_1016_j_bcp_2013_07_007 crossref_primary_10_3389_fnmol_2017_00338 crossref_primary_10_1016_j_ceca_2017_07_007 crossref_primary_10_3389_fnbeh_2021_649129 crossref_primary_10_1016_j_bbr_2013_11_009 crossref_primary_10_1007_s10059_012_2172_x crossref_primary_10_1016_j_neuropharm_2020_108256 crossref_primary_10_1016_j_neuropharm_2019_107705 crossref_primary_10_3389_fncel_2014_00466 crossref_primary_10_1371_journal_pone_0087040 crossref_primary_10_1038_npp_2014_265 crossref_primary_10_1016_j_neuropharm_2014_11_014 crossref_primary_10_1523_JNEUROSCI_4647_12_2013 crossref_primary_10_1016_j_pnpbp_2020_109873 crossref_primary_10_1101_cshperspect_a039701 crossref_primary_10_1523_JNEUROSCI_6246_11_2012 crossref_primary_10_3389_fnsys_2017_00050 crossref_primary_10_1016_j_neuropharm_2013_09_008 crossref_primary_10_1016_j_bcp_2017_06_113 crossref_primary_10_3390_molecules24050944 crossref_primary_10_1111_ejn_13425 crossref_primary_10_1038_s41380_023_02194_w crossref_primary_10_1016_j_phrs_2015_11_016 crossref_primary_10_1016_j_brainres_2012_09_036 crossref_primary_10_1124_mol_113_087346 crossref_primary_10_1111_ejn_12491 crossref_primary_10_1371_journal_pone_0082719 crossref_primary_10_1007_s00213_021_05949_x crossref_primary_10_1523_ENEURO_0418_19_2020 crossref_primary_10_1101_lm_031237_113 crossref_primary_10_1016_j_neuroscience_2013_08_008 crossref_primary_10_2174_1570159X19666210716112351 crossref_primary_10_1177_1099800418781914 crossref_primary_10_1371_journal_pone_0068300 crossref_primary_10_3390_cells12162051 crossref_primary_10_1111_bph_15762 crossref_primary_10_1016_j_mcna_2021_08_011 crossref_primary_10_1016_j_ypmed_2016_08_009 crossref_primary_10_1016_j_pneurobio_2014_10_002 crossref_primary_10_1016_j_physbeh_2024_114639 crossref_primary_10_3390_brainsci10120928 crossref_primary_10_1126_scisignal_aba1169 crossref_primary_10_1371_journal_pone_0182142 crossref_primary_10_31887_DCNS_2017_19_3_gkoob crossref_primary_10_3389_fncir_2022_867053 crossref_primary_10_1016_j_tins_2012_02_003 crossref_primary_10_1038_mp_2017_7 crossref_primary_10_1016_j_neuroscience_2015_07_052 crossref_primary_10_1016_j_celrep_2019_04_094 crossref_primary_10_1111_ejn_12114 crossref_primary_10_1172_JCI177833 crossref_primary_10_1080_00952990_2016_1197232 crossref_primary_10_1097_j_pain_0000000000000993 crossref_primary_10_3831_KPI_2020_23_001 crossref_primary_10_1021_acschemneuro_8b00492 crossref_primary_10_1017_jsc_2018_27 |
Cites_doi | 10.1016/S0896-6273(02)00625-6 10.1016/j.neuron.2008.09.009 10.1113/jphysiol.2008.162743 10.1523/JNEUROSCI.22-08-03269.2002 10.1038/npp.2008.143 10.1016/S0022-3565(25)39530-3 10.1002/cne.20417 10.1523/JNEUROSCI.15-07-05379.1995 10.1038/34413 10.1523/JNEUROSCI.3918-08.2008 10.1126/science.1099420 10.1002/1098-2396(200008)37:2<125::AID-SYN7>3.0.CO;2-7 10.1523/JNEUROSCI.21-05-01452.2001 10.1101/lm.70004 10.1073/pnas.0510715103 10.1523/JNEUROSCI.2950-09.2009 10.1038/35079077 10.1523/JNEUROSCI.5095-09.2010 10.1016/j.bcp.2009.05.014 10.1016/j.neuropharm.2004.07.006 10.1523/JNEUROSCI.1001-08.2008 10.1523/JNEUROSCI.5179-05.2006 10.1523/JNEUROSCI.1943-10.2010 10.1038/nrn2234 10.1523/JNEUROSCI.1312-04.2004 10.1523/JNEUROSCI.4331-05.2006 10.1073/pnas.0909184107 10.1016/S0896-6273(00)00042-8 10.1016/j.neuropharm.2010.06.004 10.1016/j.neuropharm.2006.02.003 10.1113/jphysiol.2006.117069 10.1016/S0896-6273(03)00021-7 10.1523/JNEUROSCI.21-15-05841.2001 10.1523/JNEUROSCI.16-07-02411.1996 10.1016/S0028-3908(01)00137-X 10.1073/pnas.88.5.1859 10.1016/j.neuroscience.2006.11.011 10.1113/jphysiol.1992.sp019136 10.1016/0306-4522(94)00536-E 10.1016/S0306-4522(00)00274-8 10.1038/37120 |
ContentType | Journal Article |
Copyright | Copyright © 2011 the authors 0270-6474/11/316710-11$15.00/0 2011 |
Copyright_xml | – notice: Copyright © 2011 the authors 0270-6474/11/316710-11$15.00/0 2011 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1523/JNEUROSCI.5671-10.2011 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1529-2401 |
EndPage | 6720 |
ExternalDocumentID | PMC3118498 21543600 10_1523_JNEUROSCI_5671_10_2011 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIDA NIH HHS grantid: DA25875 – fundername: NIDA NIH HHS grantid: P01 DA019695 – fundername: NIDA NIH HHS grantid: R01 DA025875 – fundername: NIDA NIH HHS grantid: R01 DA015918 – fundername: NIDA NIH HHS grantid: DA019695 – fundername: NIDA NIH HHS grantid: DA015918 |
GroupedDBID | --- -DZ -~X .55 18M 2WC 34G 39C 3O- 53G 5GY 5RE 5VS AAFWJ AAJMC AAYXX ABBAR ABIVO ACGUR ACNCT ADBBV ADCOW ADHGD AENEX AETEA AFCFT AFFNX AFOSN AFSQR AHWXS ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CITATION CS3 DIK DU5 E3Z EBS EJD F5P GX1 H13 HYE H~9 KQ8 L7B MVM OK1 P0W P2P QZG R.V RHI RPM TFN TR2 W8F WH7 WOQ X7M XJT YBU YHG YKV YNH YSK AFHIN AIZTS CGR CUY CVF ECM EIF NPM RHF 7X8 5PM |
ID | FETCH-LOGICAL-c413t-2251979ec98e9549ec5bbc46bb1b7e7cdcae06e34cc9f4e33d81b7d5cdd2861f3 |
ISSN | 0270-6474 1529-2401 |
IngestDate | Thu Aug 21 13:18:49 EDT 2025 Fri Sep 05 10:53:13 EDT 2025 Wed Feb 19 02:36:00 EST 2025 Thu Apr 24 23:02:21 EDT 2025 Tue Jul 01 05:27:18 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 18 |
Language | English |
License | https://creativecommons.org/licenses/by-nc-sa/4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c413t-2251979ec98e9549ec5bbc46bb1b7e7cdcae06e34cc9f4e33d81b7d5cdd2861f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.jneurosci.org/content/jneuro/31/18/6710.full.pdf |
PMID | 21543600 |
PQID | 865187829 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3118498 proquest_miscellaneous_865187829 pubmed_primary_21543600 crossref_primary_10_1523_JNEUROSCI_5671_10_2011 crossref_citationtrail_10_1523_JNEUROSCI_5671_10_2011 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-05-04 2011-May-04 20110504 |
PublicationDateYYYYMMDD | 2011-05-04 |
PublicationDate_xml | – month: 05 year: 2011 text: 2011-05-04 day: 04 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of neuroscience |
PublicationTitleAlternate | J Neurosci |
PublicationYear | 2011 |
Publisher | Society for Neuroscience |
Publisher_xml | – name: Society for Neuroscience |
References | Kalivas (2023041303502037000_31.18.6710.15) 1993; 267 2023041303502037000_31.18.6710.1 2023041303502037000_31.18.6710.27 2023041303502037000_31.18.6710.2 2023041303502037000_31.18.6710.28 2023041303502037000_31.18.6710.29 2023041303502037000_31.18.6710.23 2023041303502037000_31.18.6710.24 Schoffelmeer (2023041303502037000_31.18.6710.34) 2002; 22 Kalivas (2023041303502037000_31.18.6710.16) 1995; 15 2023041303502037000_31.18.6710.25 2023041303502037000_31.18.6710.26 2023041303502037000_31.18.6710.41 2023041303502037000_31.18.6710.20 2023041303502037000_31.18.6710.42 2023041303502037000_31.18.6710.21 2023041303502037000_31.18.6710.22 Ranaldi (2023041303502037000_31.18.6710.30) 2001; 21 Klink (2023041303502037000_31.18.6710.19) 2001; 21 2023041303502037000_31.18.6710.5 2023041303502037000_31.18.6710.6 Vezina (2023041303502037000_31.18.6710.37) 1996; 16 2023041303502037000_31.18.6710.3 2023041303502037000_31.18.6710.4 2023041303502037000_31.18.6710.9 2023041303502037000_31.18.6710.7 2023041303502037000_31.18.6710.8 Johnson (2023041303502037000_31.18.6710.14) 1992; 450 2023041303502037000_31.18.6710.38 2023041303502037000_31.18.6710.17 2023041303502037000_31.18.6710.39 2023041303502037000_31.18.6710.18 2023041303502037000_31.18.6710.12 2023041303502037000_31.18.6710.13 2023041303502037000_31.18.6710.35 2023041303502037000_31.18.6710.36 2023041303502037000_31.18.6710.31 2023041303502037000_31.18.6710.10 2023041303502037000_31.18.6710.32 2023041303502037000_31.18.6710.11 2023041303502037000_31.18.6710.33 2023041303502037000_31.18.6710.40 |
References_xml | – ident: 2023041303502037000_31.18.6710.22 doi: 10.1016/S0896-6273(02)00625-6 – ident: 2023041303502037000_31.18.6710.10 doi: 10.1016/j.neuron.2008.09.009 – ident: 2023041303502037000_31.18.6710.40 doi: 10.1113/jphysiol.2008.162743 – volume: 22 start-page: 3269 year: 2002 ident: 2023041303502037000_31.18.6710.34 article-title: Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation publication-title: J Neurosci doi: 10.1523/JNEUROSCI.22-08-03269.2002 – ident: 2023041303502037000_31.18.6710.9 doi: 10.1038/npp.2008.143 – volume: 267 start-page: 486 year: 1993 ident: 2023041303502037000_31.18.6710.15 article-title: Involvement of N-methyl-d-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(25)39530-3 – ident: 2023041303502037000_31.18.6710.24 doi: 10.1002/cne.20417 – volume: 15 start-page: 5379 year: 1995 ident: 2023041303502037000_31.18.6710.16 article-title: D1 receptors modulate glutamate transmission in the ventral tegmental area publication-title: J Neurosci doi: 10.1523/JNEUROSCI.15-07-05379.1995 – ident: 2023041303502037000_31.18.6710.25 doi: 10.1038/34413 – ident: 2023041303502037000_31.18.6710.29 doi: 10.1523/JNEUROSCI.3918-08.2008 – ident: 2023041303502037000_31.18.6710.35 doi: 10.1126/science.1099420 – ident: 2023041303502037000_31.18.6710.6 doi: 10.1002/1098-2396(200008)37:2<125::AID-SYN7>3.0.CO;2-7 – volume: 21 start-page: 1452 year: 2001 ident: 2023041303502037000_31.18.6710.19 article-title: Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei publication-title: J Neurosci doi: 10.1523/JNEUROSCI.21-05-01452.2001 – ident: 2023041303502037000_31.18.6710.27 doi: 10.1101/lm.70004 – ident: 2023041303502037000_31.18.6710.20 doi: 10.1073/pnas.0510715103 – ident: 2023041303502037000_31.18.6710.4 doi: 10.1523/JNEUROSCI.2950-09.2009 – ident: 2023041303502037000_31.18.6710.36 doi: 10.1038/35079077 – ident: 2023041303502037000_31.18.6710.13 doi: 10.1523/JNEUROSCI.5095-09.2010 – ident: 2023041303502037000_31.18.6710.28 doi: 10.1016/j.bcp.2009.05.014 – ident: 2023041303502037000_31.18.6710.39 doi: 10.1016/j.neuropharm.2004.07.006 – ident: 2023041303502037000_31.18.6710.1 doi: 10.1523/JNEUROSCI.1001-08.2008 – ident: 2023041303502037000_31.18.6710.33 doi: 10.1523/JNEUROSCI.5179-05.2006 – ident: 2023041303502037000_31.18.6710.12 doi: 10.1523/JNEUROSCI.1943-10.2010 – ident: 2023041303502037000_31.18.6710.17 doi: 10.1038/nrn2234 – ident: 2023041303502037000_31.18.6710.3 doi: 10.1523/JNEUROSCI.1312-04.2004 – ident: 2023041303502037000_31.18.6710.11 doi: 10.1523/JNEUROSCI.4331-05.2006 – ident: 2023041303502037000_31.18.6710.31 doi: 10.1073/pnas.0909184107 – ident: 2023041303502037000_31.18.6710.21 doi: 10.1016/S0896-6273(00)00042-8 – ident: 2023041303502037000_31.18.6710.42 doi: 10.1016/j.neuropharm.2010.06.004 – ident: 2023041303502037000_31.18.6710.7 doi: 10.1016/j.neuropharm.2006.02.003 – ident: 2023041303502037000_31.18.6710.23 doi: 10.1113/jphysiol.2006.117069 – ident: 2023041303502037000_31.18.6710.32 doi: 10.1016/S0896-6273(03)00021-7 – volume: 21 start-page: 5841 year: 2001 ident: 2023041303502037000_31.18.6710.30 article-title: Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine publication-title: J Neurosci doi: 10.1523/JNEUROSCI.21-15-05841.2001 – volume: 16 start-page: 2411 year: 1996 ident: 2023041303502037000_31.18.6710.37 article-title: D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area publication-title: J Neurosci doi: 10.1523/JNEUROSCI.16-07-02411.1996 – ident: 2023041303502037000_31.18.6710.8 doi: 10.1016/S0028-3908(01)00137-X – ident: 2023041303502037000_31.18.6710.38 doi: 10.1073/pnas.88.5.1859 – ident: 2023041303502037000_31.18.6710.2 doi: 10.1016/j.neuroscience.2006.11.011 – ident: 2023041303502037000_31.18.6710.5 – volume: 450 start-page: 455 year: 1992 ident: 2023041303502037000_31.18.6710.14 article-title: Two types of neurone in the rat ventral tegmental area and their synaptic inputs publication-title: J Physiol doi: 10.1113/jphysiol.1992.sp019136 – ident: 2023041303502037000_31.18.6710.41 doi: 10.1016/0306-4522(94)00536-E – ident: 2023041303502037000_31.18.6710.18 doi: 10.1016/S0306-4522(00)00274-8 – ident: 2023041303502037000_31.18.6710.26 doi: 10.1038/37120 |
SSID | ssj0007017 |
Score | 2.319281 |
Snippet | Drug-induced changes in synaptic strength are hypothesized to contribute to appetitive behavior and addiction. Nicotine, the major addictive substance in... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 6710 |
SubjectTerms | Action Potentials - drug effects Action Potentials - physiology Analysis of Variance Animals Dopamine - metabolism Electrophysiology Immunohistochemistry Long-Term Potentiation - drug effects Long-Term Potentiation - physiology Male Neurons - drug effects Neurons - metabolism Nicotine - pharmacology Nicotinic Agonists - pharmacology Rats Rats, Sprague-Dawley Receptors, AMPA - metabolism Receptors, N-Methyl-D-Aspartate - metabolism Receptors, Nicotinic - metabolism Synapses - drug effects Synapses - physiology Ventral Tegmental Area - drug effects Ventral Tegmental Area - physiology |
Title | Nicotine Potentiation of Excitatory Inputs to Ventral Tegmental Area Dopamine Neurons |
URI | https://www.ncbi.nlm.nih.gov/pubmed/21543600 https://www.proquest.com/docview/865187829 https://pubmed.ncbi.nlm.nih.gov/PMC3118498 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKeOEFAeNSbvID4mVKl8RJnDxW1dhFajW0Fu0tih13G6JJBanE-CP8Xc6xncTdJgF7idq0dpJ-X4-Pj8_5TMgHlPAugoJ7ionEgyFAeqmMCq8MmFKMo2gWxiGns-RoEZ2cx-eDwW8na2nTiJH8dWddyX1QhXOAK1bJ_geyXadwAl4DvnAEhOH4TxgjjA26iad1g1k_nft38FNi7Riunx9X602jZRy-mEDu3lxdWEX_MXiM4EKvixV2onU6bPDua08ix2V1xC-dlNnalqpf90Q7xPD8RbunurpquqDzVB6qS5P8Y6rb985GbuQBQ6mx5zuRRyetdHbz-saChRzmppHZhmekrIUN9ZJO4JpgOxBYqqWOQU24zXpV9q0unbtt-GMtQHEyw_zHs8nxKIaGHua5-8aWO2xYrzQdwNeJWOL7_UDYpSeeTicMJl5Rlj4gD0MOThmu9n_uZei5r7dy7p7Plp7DTezffQtac9pcb9sBujWruZmc63g78yfkscWcjg3nnpKBqp6R3XEFnFpd049UJw7rFZldsmhpSF0a0npJexpSQ0Pa1NTSkHY0pEhD2tKQWho-J4tPB_PJkWd36_AkOEKNF-oa6EzJLFW4dqxkLISMEiECwRWXpSyUnygWSZktI8VYCTMmXsayLMM0CZbsBdmp6kq9IrTMhBKCSQGDQxT7S1SQVTDaYP6WKAM-JHH7E-bSStnjjirfcpzSAgp5h0KOKOBpRGFI9rt2ayPm8tcWtEUoB7uLi2lFperNjzxN4iAF9zobkpcGsK7LFukh4VtQdl9ASfftT6qrSy3tbmn3-t4t35BH_V_1Ldlpvm_UO3CbG_FeU_gPDWvDQA |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nicotine+Potentiation+of+Excitatory+Inputs+to+Ventral+Tegmental+Area+Dopamine+Neurons&rft.jtitle=The+Journal+of+neuroscience&rft.au=Mao%2C+Danyan&rft.au=Gallagher%2C+Keith&rft.au=McGehee%2C+Daniel+S.&rft.date=2011-05-04&rft.pub=Society+for+Neuroscience&rft.issn=0270-6474&rft.eissn=1529-2401&rft.volume=31&rft.issue=18&rft.spage=6710&rft.epage=6720&rft_id=info:doi/10.1523%2FJNEUROSCI.5671-10.2011&rft_id=info%3Apmid%2F21543600&rft.externalDocID=PMC3118498 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-6474&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-6474&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-6474&client=summon |